(Q28286274)

1

0 references

Marjolein Bannink

2

0 references

Arthur R Van Gool

3

0 references

Wim H J Kruit

4

0 references

Gerrit Stoter

International Journal of Clinical Pharmacy

5

0 references

language of work or name

English

0 references

publication date

December 2005

0 references

published in

0 references

volume

27

0 references

issue

6

0 references

page(s)

423-31

0 references

cites work

Interferon alfa induces leukocyte capillary trapping in rat retinal microcirculation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11096-005-1319-7

Effect of interferon on glucose tolerance and insulin sensitivity.

21 January 2018

1 reference

12 December 2020

Modulation of alpha-interferon's antiviral and clinical effects by aspirin, acetaminophen, and prednisone in healthy volunteers

1 reference

12 December 2020

Inflammatory demyelinating polyneuropathy: a complication of immunotherapy in malignant melanoma

1 reference

12 December 2020

Uncommon side-effects of interferon

1 reference

12 December 2020

Expression of ICAM-1, B7.1 and TPO on human thyrocytes induced by IFN-alpha

1 reference

12 December 2020

Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review

1 reference

12 December 2020

Acute reversible rhabdomyolysis during interferon alpha2B therapy for hepatitis C

1 reference

12 December 2020

Cytokines and feeding

1 reference

12 December 2020

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

12 December 2020

1 reference

12 December 2020

The phenomenology and treatment of interferon-induced depression.

1 reference

12 December 2020

The effect of interferon on mouse myocardial capillaries: an ultrastructural study

1 reference

12 December 2020

Immune-mediated side-effects of cytokines in humans

1 reference

12 December 2020

Nephrotoxicity of interferon alfa-ribavirin therapy for chronic hepatitis C.

1 reference

12 December 2020

Lipoprotein changes in patients with chronic hepatitis C treated with interferon-alpha.

1 reference

12 December 2020

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

1 reference

12 December 2020

Interferon-induced hypopituitarism

1 reference

12 December 2020

Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha

1 reference

12 December 2020

Multiple sclerosis-like disease secondary to alpha interferon

1 reference

12 December 2020

Effects of long-term interferon-alpha treatment on glucose tolerance in patients with chronic hepatitis C

1 reference

12 December 2020

A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma

1 reference

12 December 2020

Differential effect of IFNalpha-2b on the cytochrome P450 enzyme system: a potential basis of IFN toxicity and its modulation by other drugs.

1 reference

12 December 2020

Cutaneous reactions to recombinant cytokine therapy

1 reference

12 December 2020

Early diagnosis of interferon-induced myocardial disorder in patients with chronic hepatitis C: evaluation by myocardial imaging with 123I-BMIPP

1 reference

12 December 2020

Type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy

1 reference

12 December 2020

Mechanisms and management of toxicities associated with high-dose interferon alfa-2b therapy

1 reference

12 December 2020

Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.

1 reference

12 December 2020

Side effects of therapy of hepatitis C and their management

1 reference

12 December 2020

Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C

1 reference

12 December 2020

Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment

1 reference

12 December 2020

Clinical toxicity of interferons in cancer patients: a review

1 reference

12 December 2020

Interferon-alpha 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial

1 reference

12 December 2020

Pleural effusion during interferon treatment for chronic hepatitis C

1 reference

12 December 2020

IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2.

1 reference

12 December 2020

Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia

1 reference

12 December 2020

Reversible hypopituitarism after interferonalfa therapy

1 reference

12 December 2020

Cytokines and brain function: relevance to interferon-alpha-induced mood and cognitive changes.

1 reference

12 December 2020

Oculo-bulbar myasthenia gravis induced by cytokine treatment of a patient with metastasized renal cell carcinoma

1 reference

12 December 2020

Elevated plasma nitrate levels in depressive states

1 reference

12 December 2020

Retinal complications during interferon therapy for chronic hepatitis C

1 reference

12 December 2020

Myasthenia gravis during interferon alfa therapy

1 reference

12 December 2020

Low-titre auto-antibodies predict autoimmune disease during interferon-alpha treatment of chronic hepatitis C

1 reference

12 December 2020

1 reference

12 December 2020

Interferon-alpha stimulates the hypothalamic-pituitary-adrenal axis in vivo and in vitro

1 reference

12 December 2020

Human leukocyte interferon preparation-mediated block of granulopoietic differentiation in vitro

1 reference

12 December 2020

Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma.

1 reference

12 December 2020

Mechanisms of fever induced by recombinant human interferon

1 reference

12 December 2020

Fatal rhabdomyolysis and multiple organ failure associated with adjuvant high-dose interferon alfa in malignant melanoma

1 reference

12 December 2020

[Mononeuropathy multiplex in a patient receiving interferon alpha therapy for chronic hepatitis C]

1 reference

12 December 2020

Axonal neuropathy and hearing loss associated with alpha interferon treatment in chronic hepatitis B: a case report.

1 reference

12 December 2020

Impaired platelet aggregation in melanoma patients treated with interferon-alpha-2b adjuvant therapy

1 reference

12 December 2020

Pulmonary side effects of interferon‐α therapy in patients with hematological malignancies

1 reference

12 December 2020

Suppressive effect of interferon on erythroid cell proliferation

1 reference

12 December 2020

Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice.

1 reference

12 December 2020

Acute effects of interferon-alpha administration on testosterone concentrations in healthy men

1 reference

12 December 2020

Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. Groupe Français d'Immunothérapie

1 reference

12 December 2020

Development of myasthenia gravis during interferon-alpha treatment for anti-HCV positive chronic hepatitis

1 reference

12 December 2020

HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C

1 reference

12 December 2020

1 reference

12 December 2020

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment

1 reference

12 December 2020

Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.

1 reference

12 December 2020

Interferon-alpha induced autoimmune hepatitis in a patient with Philadelphia chromosome-positive chronic myeloid leukemia with cytogenetically normal T lymphocytes

1 reference

12 December 2020

Cytokines and psychopathology: lessons from interferon-alpha

1 reference

12 December 2020

The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C

1 reference

12 December 2020

Adjuvant interferon alpha 2b in high risk melanoma - the Scottish study

1 reference

12 December 2020

Bell's palsy during interferon therapy for chronic hepatitis C infection in patients with haemorrhagic disorders

1 reference

12 December 2020

Divergent effects of cytokines on human leukocyte antigen-DR antigen expression of neoplastic and non-neoplastic human thyroid cells

1 reference

12 December 2020

Interferon-alpha induced Raynaud's syndrome

1 reference

12 December 2020

Neuropsychiatric side effects of interferon-alfa therapy

1 reference

12 December 2020

Interferon-induced organic mental disorders associated with unsuspected pre-existing neurologic abnormalities.

1 reference

12 December 2020

IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity

1 reference

12 December 2020

Seizures during alpha interferon therapy

1 reference

12 December 2020

Neurotransmitter changes by interferon-alpha and therapeutic implications

1 reference

12 December 2020

Rhabdomyolysis, when observed with high-dose interferon-alfa (HDI) therapy, does not always exclude resumption of HDI

1 reference

12 December 2020

Vascular events associated with alpha interferon therapy

1 reference

12 December 2020

Current status of the use of growth factors and other adjuvant medications in patients receiving peginterferon and ribavirin.

1 reference

12 December 2020

Cardiotoxicity of interferon. A review of 44 cases

1 reference

12 December 2020

The neurologic basis of fever

1 reference

12 December 2020

Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis C.

1 reference

12 December 2020

Sudden hearing loss associated with interferon.

1 reference

12 December 2020

Dermatologic disease during interferon-alpha therapy for chronic viral hepatitis

1 reference

12 December 2020